12.6
Expériences en cross-over
Les expériences en cross-over, également appelées plans à mesures répétées, sont un type de plan d’étude dans lequel toutes les unités expérimentales…
Un plan d’étude croisé est également appelé plan de mesures répétées, où les unités expérimentales reçoivent tous les traitements à différentes périodes.
Par exemple, considérons un essai clinique comparant le médicament A et le médicament B sur 10 patients asthmatiques divisés au hasard en groupe un et en groupe deux.
Tout d'abord, chaque groupe reçoit différents médicaments pendant deux semaines, en enregistrant leur effet sur la physiologie du patient. Ceci est suivi d'une période de sevrage, pour éliminer le médicament du corps du patient.
Maintenant, les groupes sont intervertis de sorte que le deuxième groupe reçoit le médicament A et le premier groupe reçoit le médicament B. C’est ce qu’on appelle un plan croisé. Dans cette conception, les sujets agissent comme leurs propres contrôles, et leurs caractéristiques ne sont pas modifiées tout au long de l’étude. Il élimine également les variabilités entre les sujets.
Cette conception est généralement utilisée dans les essais cliniques de phase avancée impliquant des médicaments qui aident à contrôler les symptômes et non à les guérir complètement.
Par exemple, dans l’exemple précédent, le médicament B n’aura pas l’occasion de démontrer son efficacité si le médicament A guérit le patient pendant les premières règles.
View the full transcript and gain access to JoVE Core videos
Q1: What is a crossover experiment and how does it differ from other study designs?
A crossover experiment, also called a repeated measurements design, exposes all experimental units to every treatment across different time periods. Unlike simple randomized trials, subjects act as their own controls, eliminating inter-subject variability. This approach is particularly valuable in clinical trials where patients receive all treatments sequentially, with washout periods between exposures to clear previous treatments from the body.
Q2: Why is a washout period necessary in crossover studies?
A washout period eliminates residual effects of the previous treatment from the subject's body before introducing the next treatment. This prevents carryover effects that could confound results and compromise data validity. Without adequate washout time, the lingering effects of one drug could artificially influence responses to the subsequent treatment, making it impossible to isolate each treatment's true effect.
Q3: When are crossover designs most appropriate in pharmaceutical research?
Crossover designs are ideal for late-phase clinical trials testing drugs that control symptoms rather than cure diseases completely. They work well for comparing bioavailability or drug ingestion in the human body against reference drugs. However, crossover designs are unsuitable for chronic, stable diseases or when drugs provide complete cures, as treatment effects would prevent meaningful comparison of subsequent treatments.
Q4: How do subjects serve as their own controls in crossover experiments?
In crossover designs, each subject receives all treatments sequentially, allowing researchers to compare treatment effects within the same individual. Since subjects' characteristics remain constant throughout the study, differences in outcomes directly reflect treatment effects rather than individual variation. This internal comparison eliminates confounding variables associated with inter-subject differences, making crossover designs more statistically powerful than between-subject comparisons.
Q5: What are the advantages of using crossover designs with smaller sample sizes?
Crossover designs require smaller sample sizes than simple randomized trials because each subject provides data for all treatment conditions. Since subjects act as their own controls, researchers can detect treatment differences more efficiently with fewer participants. This efficiency makes crossover designs cost-effective and practical in fields like psychology, pharmaceuticals, agriculture, and medicine where sample recruitment may be limited.
Q6: What is an example of how crossover experiments work in clinical drug trials?
In a typical example, asthmatic patients are randomly divided into two groups. Group one receives drug A for two weeks while group two receives drug B, with effects recorded. After a washout period, the groups switch treatments. This design allows researchers to compare both drugs' effectiveness within the same patients, ensuring fair comparison while controlling for individual patient characteristics that might influence drug response.
Q7: Why are crossover designs unsuitable for studying chronic diseases?
Crossover designs fail for chronic, stable diseases because if the first treatment cures or substantially improves the condition, the disease may not return during the washout period. This prevents meaningful evaluation of subsequent treatments. For example, if drug A cures asthma in the first period, drug B cannot demonstrate its effectiveness in the second period, making treatment comparison impossible and invalidating the study's conclusions.